Effective Treatment of Ductal Carcinoma In Situ with a HER-2-Targeted Alpha-Particle Emitting 　Radionuclide in a Preclinical model of Human Breast cancer

トップページ >
業績 >

Effective Treatment of Ductal Carcinoma In Situ with a HER-2-Targeted Alpha-Particle Emitting 　Radionuclide in a Preclinical model of Human Breast cancer

Takahiro Yoshida, Kideok Jin, Hong Song, Sunju Park, David L Huso, Zhe Zhang, Han Liangfeng, Charles Zhu, Frank Bruchertseifer, Alfred Morgenstern, George Sgouros, Saraswati Sukumar

2016.11.30

<img src="https://www.tksbizan.com/app/wp-content/themes/tksbizan/image/logo.png" alt="徳島大学 胸部・内分泌・腫瘍外科" data-eio="l">

Effective Treatment of Ductal Carcinoma In Situ with a HER-2-Targeted Alpha-Particle Emitting Radionuclide in a Preclinical model of Human Breast cancer

<img src="https://www.tksbizan.com/app/wp-content/themes/tksbizan/image/f-logo.png" alt="徳島大学大学院 医歯薬学研究部 胸部・内分泌・腫瘍外科" data-eio="l">

Effective Treatment of Ductal Carcinoma In Situ with a HER-2-Targeted Alpha-Particle Emitting 　Radionuclide in a Preclinical model of Human Breast cancer